Abstract:Background The death rate was overwhelmingly high during COVID 19 pandemic with very few treatment options and the main cause leading to
death being the cytokine storm.Monoclonal antibodies like Tocilizumab ( IL-6 receptor inhibitor) was said to be an effective treatment option in
severe COVID 19 patients with increased inammatory markers. Objectives To determine the outcome of monoclonal antibodies in COVID 19
patients. To determine the risk of mechanical ventilation in patients who are treated with monoclon… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.